Dyania Health
Jersey City
About Dyania Health
Dyania’s mission is to deploy their medically specialized and proprietary Synapsis AI to automate manual chart review, one of the most inefficient and time-consuming processes in modern healthcare, thereby empowering clinicians to deliver optimal care, precisely when patients need it. Dyania’s system is being used at large healthcare systems to unlock enterprise-wide clinical trial pre-screening, run automated chart review for observational studies, and automate complex registry reporting, dramatically reducing manual workloads and ensuring more accurate and timely patient care.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $17.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2024)
- Website: dyaniahealth.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Clinical Trials, Electronic Health Record (EHR), Generative AI, Health Care
Social Profiles
Canonical: https://fsome.com/organization/dyania-health-55958 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.